Board Meeting

NECTAR LIFESCIENCES LTD.

NSE : NECLIFEBSE : 532649ISIN CODE : INE023H01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE32.83-0.34 (-1.03 %)
PREV CLOSE ( ) 33.17
OPEN PRICE ( ) 32.73
BID PRICE (QTY) 32.78 (180)
OFFER PRICE (QTY) 32.95 (364)
VOLUME 32329
TODAY'S LOW / HIGH ( )32.35 33.11
52 WK LOW / HIGH ( )16.35 45.7
NSE32.95-0.2 (-0.6 %)
PREV CLOSE( ) 33.15
OPEN PRICE ( ) 32.45
BID PRICE (QTY) 32.80 (782)
OFFER PRICE (QTY) 32.95 (1508)
VOLUME 106750
TODAY'S LOW / HIGH( ) 32.25 33.05
52 WK LOW / HIGH ( )16.5 45.7

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.